In human and murine AML, AHR activation impairs innate lymphoid cell (ILC) development, blocking maturation, while AHR inhibition restored a normal NK cell maturation profile and sensitized leukemic blasts to NK cell-mediated killing (27, 28). Here, AHR is linked to acute myeloid leukemia.